Literature DB >> 15456717

Antivascular cancer treatments: imaging biomarkers in pharmaceutical drug development.

S M Galbraith1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 15456717     DOI： 10.1259/bjr/15255885

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  7 in total

1.  Imaging of angiogenesis: from morphology to molecules and from bench to bedside.

Authors:  Ambros J Beer; Xiaoyuan Chen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

Review 2.  Radiolabelled RGD peptides for imaging and therapy.

Authors:  F C Gaertner; H Kessler; H-J Wester; M Schwaiger; A J Beer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-02       Impact factor: 9.236

Review 3.  The role of functional imaging in the era of targeted therapy of renal cell carcinoma.

Authors:  Margarita Braunagel; Anno Graser; Maximilian Reiser; Mike Notohamiprodjo
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

4.  Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.

Authors:  Andrew X Zhu; Dushyant V Sahani; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Onofrio A Catalano; Vivek Sindhwani; Lawrence S Blaszkowsky; Sam S Yoon; Johanna Lahdenranta; Pankaj Bhargava; Jeffrey Meyerhardt; Jeffrey W Clark; Eunice L Kwak; Aram F Hezel; Rebecca Miksad; Thomas A Abrams; Peter C Enzinger; Charles S Fuchs; David P Ryan; Rakesh K Jain
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

5.  Molecular Biomarkers of Response to Antiangiogenic Therapy for Cancer.

Authors:  Dan G Duda
Journal:  ISRN Cell Biol       Date:  2012

6.  PET Imaging of Angiogenesis.

Authors:  Gang Niu; Xiaoyuan Chen
Journal:  PET Clin       Date:  2009-01-01

7.  PET Imaging of Integrin αVβ3 Expression.

Authors:  Ambros J Beer; Horst Kessler; Hans-Jürgen Wester; Markus Schwaiger
Journal:  Theranostics       Date:  2011-01-17       Impact factor: 11.556
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.